Congress On Luobing Theory Showcases Advances In TCM

KUALA LUMPUR, March 30 (Bernama) -- The 22nd International Congress on Luobing Theory, held recently in Shijiazhuang, Hebei Province, brought together experts, scholars, and industry leaders worldwide to share the latest research achievements in the innovative application of Luobing theory.

Under the theme of "Inheritance, Openness, Innovation, and Integration", participants discussed the role of Luobing theory in preventing and treating major diseases, including cardiovascular and cerebrovascular conditions, diabetes, and cancer.

At the opening ceremony, "The Compendium of Luobing Theory", compiled by Chinese Academy of Engineering academician Wu Yiling and his team, was unveiled. The four-volume work integrates recent research and clinical insights, representing a landmark contribution to the modernisation of traditional Chinese medicine (TCM) and expanding its clinical application value.

In addition, Wu, along with Jia Zhenhua, professor at the Hebei Academy of Innovative Medicine for Luobing Theory, presented reports highlighting the importance of collateral-dredging medications in managing respiratory, cardiovascular and cerebrovascular as well as other major diseases.

According to a statement, the congress also featured multiple sub-forums covering coronary heart disease, arrhythmias, heart failure, cerebrovascular diseases, diabetes, respiratory diseases, urological conditions, and cancer.

Luobing theory continues to gain global attention as an integral part of TCM, with the Overseas Forum of the 22nd International Congress on Luobing Theory scheduled to take place in Singapore in autumn 2026.

-- BERNAMA